Shukra Pharmaceuticals logo

Shukra Pharmaceuticals shareholders and shareholding pattern

NSE: SHUKRAPHARBSE: 524632Pharmaceuticals & BiotechnologySmall Cap

Last close ₹64.46up ₹1.93 (3.09%)BSE ₹64.58

Share price at the NSE close on 23 Oct 2026. Previous close ₹62.53.

52-week range of BSE trades to 23 Oct 2026
₹26.30Low, 27 May 2026₹75.50High, 6 Oct 2026
Market cap
₹2,834 Cr1,258th largest listed
P/E
78.6
P/B
31.5
Dividend yield
0.02%
ROE
47.2%
ROCE
47.3%
Debt to equity
0.06
Volume, NSE
1,99,54,06817.8% delivered

Who owns Shukra Pharmaceuticals, filing by filing

Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters51.15%
  • Foreign institutions0.44%
  • Indian institutions0.22%
  • Individuals and others48.20%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Foreign institutions
  • Indian institutions
  • Individuals and others
Per centDec 2016Filed 18 JanMar 2017Filed 13 AprJun 2017Filed 15 JulSep 2017Filed 17 OctDec 2017Filed 22 JanMar 2018Filed 21 AprJun 2018Filed 21 JulSep 2018Filed 19 OctDec 2018Filed 19 JanMar 2019Filed 2 MayJun 2019Filed 22 JulSep 2019Filed 14 OctDec 2019Filed 17 JanMar 2020Filed 23 MayJun 2020Filed 20 JulSep 2020Filed 13 OctDec 2020Filed 18 JanMar 2021Filed 21 AprJun 2021Filed 21 JulSep 2021Filed 21 OctDec 2021Filed 21 JanMar 2022Filed 21 AprJun 2022Filed 1 SepSep 2022Filed 17 OctDec 2022Filed 17 JanMar 2023Filed 17 AprJun 2023Filed 15 JulSep 2023Filed 12 OctDec 2023Filed 19 JanMar 2024Filed 21 AprJun 2024Filed 16 JulSep 2024Filed 18 OctDec 2024Filed 21 JanMar 2025Filed 21 AprJun 2025Filed 21 JulSep 2025Filed 18 OctDec 2025Filed 21 JanMar 2026Filed 17 AprJun 2026Filed 18 JulSep 2026Filed 21 Oct
49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%50.90%50.90%50.90%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%51.15%
Indian promoters49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%49.17%50.90%50.90%50.90%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%50.96%51.15%
50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%50.83%49.10%49.10%49.10%49.04%49.04%49.04%49.04%49.04%49.04%49.04%49.04%49.04%49.04%49.04%48.85%
Shares in issue15,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,67515,65,6751,09,59,7251,09,59,7251,09,59,7251,09,46,9861,09,46,9864,37,87,9444,37,87,9444,37,87,94443,78,79,44043,78,79,44043,78,79,44043,78,79,44043,78,79,44043,78,79,44043,96,14,440
Shares locked in7,69,7707,69,7707,69,7707,69,7707,69,7707,69,7707,69,7707,69,7707,69,770–––––––––––––––––––––––––––21,77,35,60021,77,35,60021,77,35,60021,94,70,600
Promoters' shares locked in7,69,7707,69,7707,69,7707,69,7707,69,7707,69,7707,69,7707,69,7707,69,770–––––––––––––––––––––––––––21,77,35,60021,77,35,60021,77,35,60021,94,70,600
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Shukra Pharmaceuticals shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

ShareholdersDec 2016Filed 18 JanMar 2017Filed 13 AprJun 2017Filed 15 JulSep 2017Filed 17 OctDec 2017Filed 22 JanMar 2018Filed 21 AprJun 2018Filed 21 JulSep 2018Filed 19 OctDec 2018Filed 19 JanMar 2019Filed 2 MayJun 2019Filed 22 JulSep 2019Filed 14 OctDec 2019Filed 17 JanMar 2020Filed 23 MayJun 2020Filed 20 JulSep 2020Filed 13 OctDec 2020Filed 18 JanMar 2021Filed 21 AprJun 2021Filed 21 JulSep 2021Filed 21 OctDec 2021Filed 21 JanMar 2022Filed 21 AprJun 2022Filed 1 SepSep 2022Filed 17 OctDec 2022Filed 17 JanMar 2023Filed 17 AprJun 2023Filed 15 JulSep 2023Filed 12 OctDec 2023Filed 19 JanMar 2024Filed 21 AprJun 2024Filed 16 JulSep 2024Filed 18 OctDec 2024Filed 21 JanMar 2025Filed 21 AprJun 2025Filed 21 JulSep 2025Filed 18 OctDec 2025Filed 21 JanMar 2026Filed 17 AprJun 2026Filed 18 JulSep 2026Filed 21 Oct
All shareholders9,7229,7069,9189,6379,5919,5779,5479,5089,4919,4689,4619,4599,4529,4559,4699,4479,4099,3459,3459,3059,2689,2399,1939,2379,2349,5319,5829,74710,96312,97414,98916,32117,84418,23120,33721,44125,64927,17328,38435,007
7777777777777777777777777777777777777777
Indian promoters7777777777777777777777777777777777777777
9,7159,6999,9119,6309,5849,5709,5409,5019,4849,4619,4549,4529,4459,4489,4629,4409,4029,3389,3389,2989,2619,2329,1869,2309,2279,5249,5759,74010,95612,96714,98216,31417,83718,22420,33021,43425,64227,16628,37735,000
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Shukra Pharmaceuticals promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is ANAR PROJECT PRIVATE LIMITED, 18.71%.

Holder
ANAR PROJECT PRIVATE LIMITEDIndian companies, trusts and others18.71%8,22,40,000100.00%
PARSHVA TEXCHEM INDIA PRIVATE LTD.Indian companies, trusts and others17.38%7,64,10,600100.00%
NAVKAR SURGICAL GUJARATIndian companies, trusts and others11.74%5,16,00,000100.00%
DAKSHESH RAMESHCHANDRA SHAHIndividuals and Hindu undivided families1.11%48,60,000100.00%
ANAR JAYESHBHAI PATELIndividuals and Hindu undivided families0.99%43,60,000100.00%
SUJAY JYOTINDRA MEHTAIndividuals and Hindu undivided families0.71%31,20,0000.00%
PAYAL SUJAY MEHTAIndividuals and Hindu undivided families0.52%22,80,0000.00%
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.

Largest public holders of Shukra Pharmaceuticals, filing by filing

Per cent, on the same shares as the split above.

HolderDec 2016Filed 18 JanMar 2017Filed 13 AprJun 2017Filed 15 JulSep 2017Filed 17 OctDec 2017Filed 22 JanMar 2018Filed 21 AprJun 2018Filed 21 JulSep 2018Filed 19 OctDec 2018Filed 19 JanMar 2019Filed 2 MayJun 2019Filed 22 JulSep 2019Filed 14 OctDec 2019Filed 17 JanMar 2020Filed 23 MayJun 2020Filed 20 JulSep 2020Filed 13 OctDec 2020Filed 18 JanMar 2021Filed 21 AprJun 2021Filed 21 JulSep 2021Filed 21 OctDec 2021Filed 21 JanMar 2022Filed 21 AprJun 2022Filed 1 SepSep 2022Filed 17 OctDec 2022Filed 17 JanMar 2023Filed 17 AprJun 2023Filed 15 JulSep 2023Filed 12 OctDec 2023Filed 19 JanMar 2024Filed 21 AprJun 2024Filed 16 JulSep 2024Filed 18 OctDec 2024Filed 21 JanMar 2025Filed 21 AprJun 2025Filed 21 JulSep 2025Filed 18 OctDec 2025Filed 21 JanMar 2026Filed 17 AprJun 2026Filed 18 JulSep 2026Filed 21 Oct
RENUKA YOGESH PARIKHNon-resident Indians15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%19.16%19.16%19.16%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.11%
YOGESH BIHARILAL PARIKHNon-resident Indians15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%–15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%15.97%–15.97%15.97%19.16%19.16%19.16%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.18%19.14%17.56%
KAILASHBEN ASHOKKUMAR PATELResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––1.25%1.79%1.86%––––––––––––
RAJESHKUMAR VITHALBHAI PATELResident individuals, over ₹2 lakh at face value2.51%2.51%2.51%2.51%–2.51%2.51%2.51%2.51%2.51%2.51%–2.51%2.51%2.51%2.51%2.51%2.51%2.51%2.51%2.51%2.51%–2.51%2.51%–––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.